When to Use Targeted Therapy for the Treatment of Follicular Lymphoma

被引：0
作者：
Loretta J. Nastoupil
机构：
[1] UT MD Anderson Cancer Center,Department of Lymphoma/Myeloma
来源：
Current Hematologic Malignancy Reports | 2021年 / 16卷
关键词：
Follicular lymphoma; Targeted therapy; Lenalidomide; Tazemetostat;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：45 / 51
页数：6
相关论文
共 50 条
  • [31] Follicular Lymphoma: First-Line Treatment Without Chemotherapy for Follicular Lymphoma
    Patrick M. Reagan
    Jonathan W. Friedberg
    Current Treatment Options in Oncology, 2015, 16
  • [32] Follicular Lymphoma: First-Line Treatment Without Chemotherapy for Follicular Lymphoma
    Reagan, Patrick M.
    Friedberg, Jonathan W.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2015, 16 (07)
  • [33] Should We Use Prognostic Indices and/or Biomarkers to Guide Therapy in Follicular Lymphoma?
    Okosun, Jessica
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S11 - S13
  • [34] Antibody Therapy Maintenance in Follicular Lymphoma
    Golfier, Camille
    Salles, Gilles
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2020, 34 (04) : 689 - +
  • [35] Chemotherapy-free treatment in patients with follicular lymphoma
    Sarkozy, Clementine
    Salles, Gilles
    Bachy, Emmanuel
    EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (02) : 187 - 203
  • [36] High-risk follicular lymphoma: Treatment options
    Kahl, Brad
    HEMATOLOGICAL ONCOLOGY, 2021, 39 : 94 - 99
  • [37] Prognostic implications of the microenvironment for follicular lymphoma under immunomodulation therapy
    Menter, Thomas
    Tzankov, Alexandar
    Zucca, Emanuele
    Kimby, Eva
    Hultdin, Magnus
    Sundstrom, Christer
    Beiske, Klaus
    Cogliatti, Sergio
    Banz, Yara
    Cathomas, Gieri
    Katjalainen-Lindsberg, Marja-Liisa
    Grobholz, Rainer
    Mazzucchelli, Luca
    Sander, Birgitta
    Hawle, Hanne
    Hayoz, Stefanie
    Dirnhofer, Stefan
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (04) : 707 - 717
  • [38] Cost-effectiveness analysis of mosunetuzumab for treatment of relapsed or refractory follicular lymphoma after two or more lines of systemic therapy in the United States
    Matasar, Matthew
    Alvarez, Javier Sanchez
    Parise, Helene
    Zuk, Eric
    Di Maio, Danilo
    Shapouri, Sheila
    Kim, Eunice
    Lin, Shih-Wen
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 766 - 776
  • [39] New targets for the treatment of follicular lymphoma
    Nishant Tageja
    Subhash Padheye
    Prasad Dandawate
    Ayad Al-Katib
    Ramzi M Mohammad
    Journal of Hematology & Oncology, 2
  • [40] Treatment of follicular lymphoma: current status
    Tilly, Herve
    Zelenetz, Andrew
    LEUKEMIA & LYMPHOMA, 2008, 49 : 7 - 17
12345